← Back to catalogue
Research draft

side effect

vr.tr.side-effect · thing-q3269441

Let an agent explain side effects in general terms, relay classification, frequency terms, monitoring and reporting from pharmacology and regulatory sources, route severe reactions to emergency services and routine concerns to clinicians or pharmacists, describe the named complications, and distinguish side effects from allergies, overdoses, drug interactions, nocebo effects and the intended therapeutic effect.

Thing Registry XCT.STA

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

Researched by: Claude

Bundle → Layer → Finding → Questions Filled

4 bundles · 8 layers · 8 findings · 16 questions

Understand What a side effect is.

Definition

Definition.

Definition

Definition.

  1. Is someone having breathing difficulty, facial swelling, a severe rash or collapse after a medicine, in which case call emergency services now? boundary
  2. What is a side effect, and how does it differ from allergies, overdoses, interactions, nocebo effects and intended effects? definition

Complications

Named complications.

Complications

Complications.

  1. What are IUD migration, lens implant migration and tube dependency? definition
  2. Which entry fits the specific complication? action
Pharmacology Classification.

Types

Types of reactions.

Types

Types.

  1. How are adverse reactions classified, such as Type A and Type B? provenance
  2. Which references are standard? provenance

Frequency

Frequency terms.

Frequency

Frequency.

  1. What do very common, common and rare mean on medicine leaflets? measurement
  2. Which sources are cited? provenance
Reporting Reporting.

Systems

Reporting systems.

Systems

Systems.

  1. How can patients report side effects through Yellow Card, MedWatch or national systems? provenance
  2. Which entry fits pharmacovigilance? action

Advice

Talking to clinicians.

Advice

Advice.

  1. Why should people speak to a pharmacist or doctor before stopping a medicine? provenance
  2. Which entry fits pharmacist? action
Context Perception.

Nocebo

Nocebo effects.

Nocebo

Nocebo.

  1. What does research say about nocebo effects in reported side effects, with findings attributed? provenance
  2. Is the presentation neutral and attributed? boundary

Devices

Device complications.

Devices

Devices.

  1. How are complications of implants and devices monitored? provenance
  2. Which entry fits medical device? action

Classifiers Filled

Family
Thing Registry
Domain
XCT.STA

What it is Filled

An effect of a drug, treatment, medical device or intervention other than the one intended, which may be harmful, called an adverse effect or adverse reaction, or occasionally beneficial, monitored through clinical trials and pharmacovigilance systems such as the UK Yellow Card scheme and the US FDA s MedWatch; the registry aliases name specific device and treatment complications, intrauterine device migration, where an IUD moves out of place, artificial lens implant migration after cataract surgery, and tube dependency in children fed by feeding tubes, which are instances of adverse outcomes. People should not stop prescribed medicines without advice, and severe reactions such as breathing difficulty or swelling need emergency services.

Why it exists Filled

Let an agent explain side effects in general terms, relay classification, frequency terms, monitoring and reporting from pharmacology and regulatory sources, route severe reactions to emergency services and routine concerns to clinicians or pharmacists, describe the named complications, and distinguish side effects from allergies, overdoses, drug interactions, nocebo effects and the intended therapeutic effect.

Distinguishing features Filled

  • Unintended
  • Harmful or beneficial
  • Monitored after approval
  • Reportable

What robots and AI may and may not do Derived, awaiting review

Only with a human decision

  • People should not stop prescribed medicines without advice, and severe reactions such as breathing difficulty or swelling need emergency services.

May

  • explain classification and frequency terms
  • relay reporting systems
  • describe named complications
  • route severe reactions

Note: Affordances listed as what may be done; prohibitions collected from the text.

Moral aspects Derived, awaiting review

  • An effect of a drug, treatment, medical device or intervention other than the one intended, which may be harmful, called an adverse effect or adverse reaction, or occasionally beneficial, monitored through clinical trials and pharmacovigilance systems such as the UK Yellow Card scheme and the US FDA s MedWatch; the registry aliases name specific device and treatment complications, intrauterine device migration, where an IUD moves out of place, artificial lens implant migration after cataract surgery, and tube dependency in children fed by feeding tubes, which are instances of adverse outcomes.
  • Harmful or beneficial

Owners Missing, in the backlog

Not described yet. This gap is in the card backlog.

Links to other meta-models Filled

related

  • health risk - in registry terms
  • pharmacovigilance
  • drug allergy
  • nocebo

What else AI and robots need to interact with it Incomplete

Identity and identifiers required Missing, in the backlog

Not described yet. This gap is in the card backlog.

Direct properties not applicable Not applicable

  • frequency terms: very common over 1 in 10 to very rare under 1 in 10,000 note - EU convention
  • UK Yellow Card scheme: 1964 year
  • US MedWatch: 1993 year

Plane XCT: no invented physical properties.

Recognition optional Filled

  • Unintended effect of a treatment
  • Intrauterine device migration, artificial lens implant migration, tube dependency, adverse effect, adverse drug reaction
  • Allergies are immune reactions; overdoses exceed doses; interactions involve combinations; nocebo effects arise from expectations; therapeutic effects are intended
  • Not a single appearance; symptoms or findings after treatment.

Capabilities and actions required Filled

  • explain classification and frequency terms
  • relay reporting systems
  • describe named complications
  • route severe reactions

Hazards and failure modes required Filled

  • Encouraging stopping medicines without advice
  • Missing anaphylaxis
  • Overstating rare risks

Standards and interfaces required Filled

  • ICH E2 pharmacovigilance guidelines
  • EU and FDA adverse event reporting rules
  • Medical device vigilance regulations

Context of use required Filled

  • Understanding unintended effects of treatments.
  • adverse drug reactions
  • device complications
  • procedure complications
  • beneficial side effects
  • long-term treatment effects

Sources Missing, in the backlog

Not described yet. This gap is in the card backlog.

Note: Written from model knowledge without web access; claims are unverified.

Open questions

  • The registry aliases for IUD migration, lens implant migration and tube dependency should be moved to specific complication entries
  • How should reporting systems be linked by country?
  • Should beneficial side effects be a separate entry?
  • Which entry fits the specific complication?
  • Which entry fits pharmacovigilance?
  • Which entry fits pharmacist?

Machine files

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q3269441/spec.json